Bienvenido(a) anuestra biblioteca de medios.
Acceda a una variedad de contenido clínico educativo sobre mácula y tratamientos periféricos, que incluyen artículos, videos clínicos y pautas de tratamiento.
BUSCAR
BÚSQUEDA AVANZADA
TIPOS DE DOCUMENTOS
FILTERS
TREATMENT
TYPE OF DOCUMENTS
Overcoming barriers to SLT as first line therapy for POAG & OH – Prof. Gus GAZZARD
12/10/2023
In this video, Prof. Gus GAZZARD , explains how to overcome barriers to SLT as first line therapy for POAG & OH. This video is from our symposium held at ESCRS 2023.
SLT: Positive implications from the LiGHT study
07/03/2023
Glaucoma is a lifelong disease that requires continual monitoring and management. For many patients, glaucoma can be controlled medically—at least for a time—but the treatment is far from perfect. Complications, side effects, and compliance are common issues for those who rely on eye drops to control IOP. Other barriers to medical treatment include nonresponse to a medication, tachyphylaxis, and financial burden.
SLT laser treatment for glaucoma – Paul Singh, MD
05/01/2023
In this interview, Inder Paul Singh, MD, explains the interest of using SLT as first line therapy for glaucoma instead of medication and the impact on the ocular surface.
"SLT not only takes away the compliance issues that are so difficult for us but it actually addresses the pathology directly."
SLT as Frontline Therapy
19/12/2022
Selective laser trabeculoplasty (SLT) has come a long way in the last few years. The practice is gaining adherents as a first-line treatment for open-angle glaucoma for multiple reasons. And to give SLT a boost and provide an uber-coherent overview of the reasons in favor of SLT, Dr. Paul Singh spoke on its behalf at ESCRS 2022 in Milan.
SLT as a first line treatment: Which patients are likely to benefit the most
19/09/2022
Dr Paul Singh explains what type of patients can benefit from SLT to treat glaucoma.
Tratamiento del glaucoma: procedimento thermocyclo
31/08/2022
Profesor. Dr. Juan R Sampaolesi
Jefe Centro de Glaucoma Buenos Aires, Argentina.
Selective Laser Trabeculoplasty
03/05/2022
Dr Franck Howes, Eye & Laser Centre Gold Coast (Australia) made a presentation on SLT (Selective Laser Trabeculoplasty) and detailed the process of applying laser energy for the control of glaucoma.
The role of Selective Laser Trabeculoplasty as a primary and secondary treatment
04/03/2022
Glaucoma is the most common optic neuropathy. The only clinically proven treatment is to reduce IOP by using medical, laser, and surgical therapies. Treatment is typically selected depending on the level of IOP, stage of the disease, pace of progression, and current and past treatment history. Glaucoma management with drops can be problematic, mainly because they can be difficult for patients to instill properly and because of the related side effects.
SubCyclo: Concept and benefits, a safe alternative to glaucoma surgery?
16/09/2021
Dr Jaromir Wasyluk